Dopamine agonists for the treatment of cocaine dependence (Q24234240)

1

0 references

Simona Vecchi

5

0 references

Silvia Minozzi

2

0 references

Pier Paolo Pani

3

0 references

Renata Solimini

object named as

Renata Solimini

4

0 references

author name string

Piergiorgio Zuccaro

Cochrane Database of Systematic Reviews

6

0 references

publication date

7 December 2011

0 references

published in

0 references

cites work

Amantadine may facilitate detoxification of cocaine addicts

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Double-blind comparison of bromocriptine and placebo in cocaine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Use of dopamine agonist pergolide in outpatient treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Bromocriptine and amantadine in cocaine detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Bromocriptine treatment for cocaine addiction: association with plasma prolactin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Amantadine does not reduce cocaine use or craving in cocaine-dependent methadone maintenance patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Amantadine in the treatment of cocaine-dependent patients with severe withdrawal symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Amantadine in the early treatment of cocaine dependence: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Treatment of Cocaine Dependence in Methadone Maintenance Clients: A Pilot Study Comparing the Efficacy of Desipramine and Amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Antisocial personality disorder as a prognostic factor for pharmacotherapy of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Adverse outcomes in a controlled trial of pergolide for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Safety, tolerability and efficacy of levodopa-carbidopa treatment for cocaine dependence: two double-blind, randomized, clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

A randomized trial of bromocriptine for cocaine users presenting to the emergency department.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Methadone tapering plus amantadine to detoxify heroin-dependent inpatients with or without an active cocaine use disorder: two randomised controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Contingency management and levodopa-carbidopa for cocaine treatment: a comparison of three behavioral targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

A screening trial of amantadine as a medication for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Cocaine Rapid Efficacy Screening Trials (CREST): lessons learned.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Cocaine Rapid Efficacy Screening Trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Randomized controlled pilot trial of cabergoline, hydergine and levodopa/carbidopa: Los Angeles Cocaine Rapid Efficacy Screening Trial (CREST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Comparison of Amantadine and Desipramine Combined with Psychotherapy for Treatment of Cocaine Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Amantadine does not modulate reinforcing, subjective, or cardiovascular effects of cocaine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Memantine increases cardiovascular but not behavioral effects of cocaine in methadone-maintained humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Bromocriptine as treatment of cocaine abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Single-dose bromocriptine reverses cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Study blinding and correlations between perceived group assignment and outcome in a cocaine pharmacotherapy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Methylphenidate treatment of cocaine abusers without attention deficit disorder: a negative report

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Double-blind evaluation of the effect of acute amantadine on cocaine craving.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Effect of a selective dopamine D1 agonist (ABT-431) on smoked cocaine self-administration in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Bromocriptine and cocaine cue reactivity in cocaine-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Effects of bromocriptine pretreatment on subjective and physiological responses to i.v. cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Dopaminergic responsivity during cocaine abstinence: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Open-label pilot study of bupropion plus bromocriptine for treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Subjective and cardiovascular effects of cocaine during treatment with amantadine and baclofen in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Bupropion hydrochloride versus placebo, in combination with cognitive behavioral therapy, for the treatment of cocaine abuse/dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

A placebo-controlled trial of L-dopa/carbidopa in early cocaine abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Benzodiazepines for alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Efficacy of Psychostimulant Drugs for Cocaine Dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Behavioral sensitization to cocaine in rats: evidence for temporal differences in dopamine D3 and D2 receptor sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Characteristics and pretreatment behaviors of clients entering drug abuse treatment: 1969 to 1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Changing pattern of drug abuse among patients entering treatment in Lazio, Italy, between 1996 and 2003: transition from heroin to cocaine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Methadone maintenance at different dosages for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Agents in development for the management of cocaine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Incentives improve outcome in outpatient behavioral treatment of cocaine dependence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Anticonvulsants for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Disulfiram for the treatment of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Antidepressants for cocaine dependence and problematic cocaine use

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Cocaine choice in humans during D-amphetamine maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Molecular mechanisms of drug reinforcement and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Change in health-related problems of cocaine consumption in Catalonia, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

The addicted human brain: insights from imaging studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Variables That Affect the Clinical Use and Abuse of Methylphenidate in the Treatment of ADHD

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Methylphenidate attenuates limbic brain inhibition after cocaine-cues exposure in cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Forebrain substrates of reward and motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

Dopamine agonists for cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3

PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003352.PUB3